OnKure Therapeutics, Inc.

Market Cap

$170M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$4.19+$1.23 (+41.55%)

Jun 5, 2026

52W High $5.2752W Low $2.00

Company Details

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate incl...

CEO

—

IPO Date

Oct 7, 2024

Website

onkuretherapeutics.com

Key Metrics TTM

Revenue

- YoY

Net Income

-$59M

EPS (Diluted)

Free Cash Flow

-$51M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 5, 2026

FY 2025

Mar 12, 2026

Q4 2025

Mar 12, 2026

Q3 2025

Nov 6, 2025

Q2 2025

Aug 12, 2025

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee